Log in
Enquire now
MBF Therapeutics

MBF Therapeutics

Company developing immunotherapies to treat the six million dogs in the US diagnosed with cancer each year.

OverviewStructured DataIssuesContributors

Contents

mbftherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Location
Ambler, Pennsylvania
Ambler, Pennsylvania
Date Incorporated
2008
CIK Number
1,458,729
Investors
Ben Franklin Technology Partners
Ben Franklin Technology Partners
Founded Date
2008
Total Funding Amount (USD)
3,000,000
Latest Funding Round Date
September 2020

Other attributes

Company Operating Status
Active

Man's Best Friends Therapeutics (MBFT) is a clinical stage animal health company that is developing gene-based check point inhibitor and immune-modulators for cancer and infectious diseases for the companion animal market using both viral and non-viral proprietary delivery systems. Their lead product is MBFT-201 for canine melanoma.

The company also has 3 infectious disease products in development..

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like MBF Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.